The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

Despite the scarcity of high quality cancer registries and lack of reliable mortality data, it is
clear that human papillomavirus (HPV)-associated diseases, particularly cervical cancer, are …

Objectives: Human papillomavirus (HPV), one of the commonest sexually transmitted
infections, may be a cofactor in HIV acquisition. We systematically reviewed the evidence for …

Purpose We aimed to characterize the antiretroviral therapy (ART) cascade among female
sex workers (FSWs) globally. Methods We systematically searched PubMed, Embase and …

These guidelines provide updated, GRADE-based recommendations on the use of vaccines
in HIVpositive adults. Several factors have made the updating of HIV-specific vaccination …

Chronic immunosuppression for various reasons is an important risk factor for persistent
infections with human papillomaviruses (HPV) and HPV-associated disease. Anogenital …

Introduction Observational studies suggest HIV and human papillomavirus (HPV) infections
may have multiple interactions. We reviewed the strength of the evidence for the influence of …

More data are needed on the role of abnormal vaginal microbiota in the natural history of
cervical human papillomavirus (HPV) infections. Our purpose was to study the prevalence of …

Mucosal immunity consists of innate and adaptive immune responses which can be
influenced by systemic immunity. Despite having been the subject of intensive studies, it is …

Background Herpes simplex virus type 2 (HSV-2) infection is a prevalent, sexually
transmitted infection with a sizable disease burden that is highest in sub-Saharan Africa …